APX2044

N/A

Report date: 2024/10/28 09:28:25
NME

Base Information

Drug NameAPX2044
Drug Alias NameAPX2044APX-2044
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiogenesis inhibitorsDNA-(apurinic or apyrimidinic site) lyase inhibitors
TargetsDNA-(apurinic or apyrimidinic site) lyase
Therapy Area/IndicationsRetinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesApexian Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesApexian Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsRetinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A